---
document_datetime: 2023-09-21 18:59:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/beromun-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: beromun-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.1450735
conversion_datetime: 2025-12-15 22:38:18.409422
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

## For procedures finalised after 31 July 2004 please refer to module 8B.

- The MAH submitted on 22 April 1999, an application for a Notification of a Type I Variation No  1  of  Annex  I,  in  order  to  apply  for  a  change  in  the  name  of  the  manufacturer  of  the medicinal  product,  pursuant  to  Article  4  of  Commission  Regulation  (EC)  No  542/95  of  10 March 1995, as amended. The procedure started on 29 April 1999. A positive Notification was signed  by  the  Head  of  Human  Unit  at  the  EMEA  on  25  May  1999  and  forwarded  to  the European Commission, which adopted a decision on 29 July 1999. (EMEA/H/C/206/I/01)
- The MAH submitted on 22 April 1999, an application for a Notification of a Type I Variation No 11 of Annex I, in order to apply for a change in the name of the manufacturer of the active substance, pursuant to Article 4 of Commission Regulation (EC) No 542/95 of 10 March 1995, as amended. The procedure started on 29 April 1999. A positive Notification was signed by the Head  of  Human  Unit  at  the  EMEA  on  25  May  1999  and  forwarded  to  the  European Commission, which adopted a decision on 29 July 1999. (EMEA/H/C/206/I/02)
- The  MAH  submitted  on  22  April  1999  a  Notification  to  the  EMEA  in  order  to  introduce changes  to  the  Package  Leaflet  not  connected  to  the  Summary  of  Product  Characteristics, pursuant to Article 10(3) of Council Directive No. 92/27/EEC of 31 March 1992. The procedure started  on  29  April  1999.  The  Notification  was  signed  by  the  Head  of  Human  Medicines Evaluation Unit on 25 May 1999 and forwarded to the European Commission, which adopted a decision on 29 July 1999 (EMEA/H/C/206/N/03).

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                                                                                                          | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Minor change in the manufacturing process of the active ingredient                                                                                             | I/04                 | I/II                     | 16.11.00                            |                                          |
| Update of Summary of Product Literature and leaflet                                                                                                            | II/05                | II                       | 23.08.01                            | 28.01.02                                 |
| Change(s) to the test method(s) and/or specifications for the active substance& Change(s) to the test method(s) and/or specifications for the finished product | II/06                | II                       | 23.01.03                            | 28.01.03                                 |
| Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                               | N/07                 | N                        | 15.11.02                            | 16.12.02                                 |
| Update of Summary of Product Characteristics and Package Leaflet                                                                                               | II/08                | II                       | 25.09.03                            | 27.01.04                                 |
| Update of or change(s) to the pharmaceutical documentation                                                                                                     | II/09                | II                       | 17.12.03                            | 23.12.03                                 |
| Renewal                                                                                                                                                        | R/10                 | R                        | 26.02.04                            | 17.06.04                                 |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.